Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Clinical trial NCT02120157 · COMPLETED
Trial details
- NCT number
- NCT02120157
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-02
- Primary completion
- 2018-06-15
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.